Pricing Log in Create free account

Cadrenal Therapeutics, Inc. (CVKD) vs Ernexa Therapeutics Inc. (ERNA)

Cadrenal Therapeutics, Inc. and Ernexa Therapeutics Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and Ernexa Therapeutics Inc. are of similar size ($3.5M and $3.5M). Across the 10 metrics below, Ernexa Therapeutics Inc. leads on 6 and Cadrenal Therapeutics, Inc. on 4.

Valuation

Metric CVKD ERNA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4.25 9.71
P/B 0.78 0.77 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 51.19 9.21
Earnings yield (449.54%) (686.60%) (33.15%)
Free cash flow yield (320.05%) (359.07%) (25.50%)

Profitability

Metric CVKD ERNA Biotechnology median
Gross margin 0.00% 83.51% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (275.16%) (321.22%) (56.36%)
Return on assets (199.59%) (176.62%) (48.04%)
Return on invested capital (427.54%) 0.00% 0.00%

Growth

Metric CVKD ERNA Biotechnology median
Revenue growth (TTM) — (78.60%) 6.02%
EPS growth (last fiscal year) 23.94% 95.42% 30.26%
Revenue growth, 5-year CAGR — (52.20%) 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD ERNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.73 2.01 4.72
Net debt to EBITDA 0.30 0.21 0.96

Dividend

Metric CVKD ERNA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CVKD ERNA Biotechnology median
Market cap 3.46m 3.54m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack